Policy & Regulation
29 June 2022 - - Japan-based pharmaceutical company Daiichi Sankyo (TSX: 4568) and British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca's (LSE: AZN) (STO: AZN) ...
29 June 2022 - - US-based gene therapy company SwanBio Therapeutics presented details about the company's ongoing natural history study of adrenomyeloneuropathy at the 8th Congress of the Eu...
29 June 2022 - - The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending approval of Lynparza for the adjuvant treatment of pati...
29 June 2022 - - The first two patients have been dosed in US-based clinical-stage microbiome company BiomX Inc's (NYSE American: PHGE) Phase 1b/2a study evaluating BX004 for the treatment of chr...
29 June 2022 - - The US Food and Drug Administration has approved the Phase 1/2a clinical trial of Singapore-based biopharmaceutical company Prestige Biopharma Ltd's first-in-class anti-PAUF mono...
29 June 2022 - German multinational pharmaceutical and life sciences company Bayer AG (ETR:BAYN) has opened a new Research and Innovation Center in the United States, the company announced on Wednesda...